Skip to main content
Signal8

EVNIN LUKE

SEC insider (Form 3/4/5 filer). CIK 0001134657. Director at Werewolf Therapeutics, Inc. (HOWL). 90 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in BOSTON, MA.

Companies EVNIN LUKE has filed insider reports for

  • Werewolf Therapeutics, Inc. (HOWL): Director
EVNIN LUKE profile photo

EVNIN LUKE

CIK: 0001134657

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)88 (97.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (1.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (1.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Werewolf Therapeutics, Inc. logo
HOWL

Werewolf Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (90 total)

  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jul 7, 2026
    Sale
    Indirect
    107.4K shares at avg. $0.31$33K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jul 6, 2026
    Sale
    Indirect
    35.8K shares at avg. $0.32$11K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 29, 2026
    Sale
    Indirect
    157.1K shares at avg. $0.30$47K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 9, 2026
    Sale
    Indirect
    76.9K shares at avg. $0.37$28K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 8, 2026
    Sale
    Indirect
    60.5K shares at avg. $0.40$24K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 5, 2026
    Sale
    Indirect
    24.9K shares at avg. $0.40$10K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 4, 2026
    Sale
    Indirect
    20.1K shares at avg. $0.44$9K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 3, 2026
    Sale
    Indirect
    29.7K shares at avg. $0.42$12K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 2, 2026
    Sale
    Indirect
    29.6K shares at avg. $0.45$13K
  • Werewolf Therapeutics, Inc. logo
    HOWL

    Werewolf Therapeutics, Inc.

    Jun 1, 2026
    Sale
    Indirect
    80.5K shares at avg. $0.47$38K

1-10 of 90

…